Search Results 41-50 of 16585 for narcolepsy
The purpose of this study is to evaluate the efficacy and safety of TAK-861 in people with narcolepsy type 1 (NT1). Participation eligibility. Participant ...
The purpose of this study is to assess the safety and effectiveness of JZP-110 in the treatment of excessive sleepiness in adult subjects with narcolepsy.
... narcolepsy. Narcolepsy is an uncontrollable desire for sleep or a sudden attack of deep sleep. This medicine is also used to treat idiopathic hypersomnia ...
The purpose of this study is to assess the safety and effectiveness of AXS-12 in narcoleptic subjects with cataplexy and excessive daytime sleepiness (EDS).
A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA · Overview · Participation eligibility.
Amphetamine is used to treat narcolepsy (sleep disorder). It is also used to treat attention-deficit hyperactivity disorder (ADHD). It belongs to the group of ...
Dextroamphetamine is used to treat attention-deficit hyperactivity disorder (ADHD) and narcolepsy (sleep disorder). It belongs to the group of medicines ...
The purpose of this study is to assess the safety and efficacy of AXS-12 in narcoleptic subjects with cataplexy and excessive daytime sleepiness (EDS).
The purpose of this study is to assess the safety and effectiveness of JZP-110 in the treatment of excessive sleepiness in adult subjects with narcolepsy. A ...
Narcolepsy diagnosis, management and research. Although narcolepsy is a rare disease, over 4,500 unique patients with narcolepsy have been seen at Mayo ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.